Finland· FI-REL-REL60729
Arexvy
A respiratorisches-synzytial-virus impfstoffe product containing respiratory syncytial virus, glycoprotein f, recombinant, stabilised in the pre-fusion conformation, adjuvanted with as01e, registered in Finland by GlaxoSmithKline Biologicals SA. The same ATC class is registered in 11 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Respiratorisches-synzytial-virus impfstoffe is registered in 11 of 19 countries.
Countries holding a registration under ATC J07BX05 (respiratorisches-synzytial-virus impfstoffe), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 7 of them publish a price we can compare per daily dose
Respiratorisches-synzytial-virus impfstoffe · ATC J07BX05
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Respiratory syncytial virus, glycoprotein F, recombinant, stabilised in the pre-fusion conformation, adjuvanted with AS01E
- Manufacturer
- GlaxoSmithKline Biologicals SA
- Country
- Finland (FI)
- ATC code
- J07BX05
- ATC class
- Respiratorisches-Synzytial-Virus Impfstoffe
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07BX05
Respiratorisches-synzytial-virus impfstoffe, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bef5bf98-aa7f-4cdd-883c-61702d46a7b4 GET /v1/drugs/bef5bf98-aa7f-4cdd-883c-61702d46a7b4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "injektiokuiva-aine ja suspensio, suspensiota varten",
"route": "Lihakseen",
"ddd_unit": null,
"strength": null,
"atc_label": "RS-virus-rokotteet",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/23/1740/001-002",
"fimea_rel_id": "REL60729",
"authorised_at": "2023-06-06"
}See everything about respiratorisches-synzytial-virus impfstoffe.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.